Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,375
Closed -$15.4K 1256
2025
Q4
$15.4K Buy
+11,375
New +$11.5K ﹤0.01% 985
2022
Q4
Sell
-38
Closed -$3.06K 639
2022
Q3
$3.06K Buy
+38
New +$5.45K ﹤0.01% 328

Other funds holding YCBD

StoneX Group's YCBD Position: Q1 2026 in Review

StoneX Group sold out of cbdMD (YCBD) in Q1 2026, closing a stake of 11,375 shares — an estimated $15.4K sold.

StoneX Group first reported a position in YCBD in Q3 2022 and held it in 2 quarters. The position peaked at $15.4K in Q4 2025. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.

  • StoneX Group reported no remaining cbdMD position as of Q1 2026 after selling out during the quarter.
  • StoneX Group sold 11,375 cbdMD shares in Q1 2026, an estimated $15.4K.
  • StoneX Group first reported a position in cbdMD in Q3 2022 and held it in 2 quarters.
  • StoneX Group's cbdMD position peaked at $15.4K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.